Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000730469-04-000058
Filing Date
2004-03-12
Accepted
2004-03-12 14:06:01
Documents
14
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K alo10k2003master.htm 10-K 941652
3 AMENDMENT NO. 3 TO THE CREDIT AGREEMENT exhibit10-1e.htm EX-10.1E 49877
4 SUPPLEMENTAL LETTER AGREEMENT exhibit10-14b.htm EX-10.14B 8042
5 AMENDED AND RESTATED ALPHARMA INC. SEVERANCE PLAN exhibit10-18a.htm EX-10.18A 29487
6 AMENDED AND RESTATED ALPHARMA INC. CHANGE IN CONTROL PLAN exhibit10-19a.htm EX-10.19A 34598
7 AMENDED AND RESTATED ALPHARMA INC. EXECUTIVE BONUS PLAN exhibit10-20a.htm EX-10.20A 19630
8 SETTLEMENT AGREEMENT exhibit10-29.htm EX-10.29 43850
9 SEPARATION LETTER AGREEMENT exhibit10-34a.htm EX-10.34A 11263
10 RATIO OF EARNINGS TO FIXED CHARGES exhibit12.htm EX-12 12249
11 LIST OF SUBSIDIARIES exhibit21.htm EX-21 5989
12 CONSENT OF PRICEWATERHOUSECOOPERS LLP consent2003-10k.htm EX-23 892
13 CERTIFICATION OF CHIEF EXECUTIVE OFFICER exhibit31-1iw.htm EX-31.1 4157
14 CERTIFICATION OF CHIEF FINANICAL OFFICER exhibit31-2mf.htm EX-31.2 4100
15 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICE AND THE PRINCIPAL FINANCIAL OFFICER exhibit32mf.htm EX-32 1564
  Complete submission text file 0000730469-04-000058.txt   1170821
Mailing Address
Business Address ONE EXECUTIVE DR P O BOX 1399 FORT LEE NJ 07024 2019477774
ALPHARMA INC (Filer) CIK: 0000730469 (see all company filings)

EIN.: 222095212 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-08593 | Film No.: 04665519
SIC: 2834 Pharmaceutical Preparations